MONTAGNANI, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 21.604
NA - Nord America 19.121
AS - Asia 9.350
SA - Sud America 1.685
Continente sconosciuto - Info sul continente non disponibili 825
AF - Africa 594
OC - Oceania 47
Totale 53.226
Nazione #
US - Stati Uniti d'America 18.636
IT - Italia 6.622
RU - Federazione Russa 4.188
GB - Regno Unito 2.981
SG - Singapore 2.678
CN - Cina 2.623
IE - Irlanda 2.077
BR - Brasile 1.361
DE - Germania 1.344
VN - Vietnam 1.234
SE - Svezia 928
FR - Francia 907
HK - Hong Kong 834
FI - Finlandia 737
UA - Ucraina 657
KR - Corea 380
IN - India 375
NL - Olanda 367
BD - Bangladesh 323
ZA - Sudafrica 323
CA - Canada 275
ES - Italia 184
PL - Polonia 117
IQ - Iraq 110
TR - Turchia 102
AR - Argentina 97
MX - Messico 97
AT - Austria 94
JP - Giappone 77
BE - Belgio 70
IR - Iran 70
PK - Pakistan 66
ID - Indonesia 65
CZ - Repubblica Ceca 57
CO - Colombia 49
EC - Ecuador 49
CI - Costa d'Avorio 48
NG - Nigeria 48
PH - Filippine 48
UZ - Uzbekistan 47
CH - Svizzera 45
SA - Arabia Saudita 38
VE - Venezuela 38
MY - Malesia 37
AU - Australia 36
AE - Emirati Arabi Uniti 34
KE - Kenya 32
EG - Egitto 31
LT - Lituania 28
CL - Cile 25
JO - Giordania 25
MA - Marocco 23
PE - Perù 23
AZ - Azerbaigian 21
JM - Giamaica 21
PT - Portogallo 21
IL - Israele 20
RO - Romania 19
PY - Paraguay 18
AL - Albania 17
BG - Bulgaria 17
CR - Costa Rica 17
DZ - Algeria 17
NP - Nepal 17
TN - Tunisia 17
EU - Europa 16
TT - Trinidad e Tobago 16
ET - Etiopia 14
LV - Lettonia 14
DK - Danimarca 13
UG - Uganda 13
HU - Ungheria 12
OM - Oman 12
UY - Uruguay 12
BO - Bolivia 11
EE - Estonia 11
KZ - Kazakistan 11
PS - Palestinian Territory 11
SK - Slovacchia (Repubblica Slovacca) 11
GR - Grecia 10
PA - Panama 10
TW - Taiwan 9
HR - Croazia 8
LB - Libano 8
NI - Nicaragua 8
NO - Norvegia 8
NZ - Nuova Zelanda 8
SV - El Salvador 8
AM - Armenia 7
BH - Bahrain 7
BY - Bielorussia 7
GE - Georgia 7
RS - Serbia 7
CY - Cipro 6
HN - Honduras 6
LK - Sri Lanka 6
LU - Lussemburgo 6
MD - Moldavia 6
SN - Senegal 6
TH - Thailandia 6
Totale 52.313
Città #
Dallas 4.148
Southend 2.391
Dublin 2.029
Singapore 1.580
San Jose 1.302
Ashburn 1.244
Moscow 1.202
Milan 1.184
Chandler 1.114
Santa Clara 982
Hong Kong 772
Beijing 695
Munich 666
Council Bluffs 627
Fairfield 558
Hefei 517
Siena 517
Rome 516
Jacksonville 512
Helsinki 500
Los Angeles 466
New York 400
Seoul 369
Ann Arbor 365
Ho Chi Minh City 345
Princeton 303
Florence 287
Woodbridge 282
Johannesburg 272
Hanoi 263
Seattle 253
Wilmington 242
Lauterbourg 238
Houston 194
Cambridge 192
The Dalles 188
Nanjing 185
Dong Ket 182
São Paulo 139
Buffalo 136
Menlo Park 136
Boardman 130
Turin 122
Frankfurt am Main 110
Naples 110
Shanghai 109
Orem 107
Chicago 105
Málaga 93
Toronto 93
Turku 88
Bologna 87
Chennai 87
Columbus 85
Nuremberg 84
London 83
San Mateo 82
Düsseldorf 79
Warsaw 74
Montreal 72
Tokyo 67
Brescia 65
Figino 64
Atlanta 63
Bengaluru 63
Nanchang 63
Brussels 62
Dearborn 61
Brooklyn 58
Genoa 58
Denver 57
Phoenix 57
Redondo Beach 54
Lancaster 53
Stockholm 52
Vienna 52
Portsmouth 51
Da Nang 50
Fremont 49
San Diego 49
Abidjan 48
Washington 46
Guangzhou 45
San Francisco 45
Baghdad 44
Boston 44
Palermo 44
Amsterdam 43
Bari 43
Catania 43
Shenyang 43
Haiphong 42
Lappeenranta 42
Rio de Janeiro 42
Tashkent 42
Poplar 38
Paris 37
Changsha 36
Mexico City 35
Abuja 34
Totale 32.277
Nome #
Utilizzo di dalbavancina nella terapia delle infezioni osteoarticolari 1.456
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 641
MENINGITE VIRALE DA HHV7. DESCRIZIONE DI UN CASO IN ADULTO IMMUNOCOMPETENTE 608
A first update on mapping the human genetic architecture of COVID-19 604
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 594
Staphylococcus aureus vaccine preclinical and clinical development: current state of the art 593
UTILIZZO DI MILTEFOSINA IN PAZIENTE CON LEISHMANIOSI MUCOSA ED INFEZIONE DA HIV 587
"EFFICACY AND SAFETY OF 2-DRUG COMBINATION ANTIRETROVIRAL THERAPY IN CLINICAL PRACTICE: RESULTS FROM A SINGLE CENTER STUDY" 579
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 537
Crisi comiziale generalizzata in giovane paziente proveniente dal Togo 499
Genetic mechanisms of critical illness in COVID-19 454
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 442
Analisi di clonalità di isolati di Streptococcus pyogenes resistenti ai macrolidi: fluttuazioni della dinamica di popolazione negli ultimi 8 anni 419
Serotype distribution, clonality and antimicrobial resistance of invasive pneumococcal isolates in a central Italian region: implications for vaccine strategies 399
An explainable model of host genetic interactions linked to COVID-19 severity 390
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 387
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 379
Pathogen-sugar interactions revealed by universal saturation transfer analysis 375
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine versus the 23-valent polysaccharide vaccine in unvaccinated HIV-infected adults: A pilot, prospective controlled study 371
Analisi della sensibilità a penicillina in isolati comunitari di Streptococcus pneumoniae: implicazioni cliniche in relazione alle concentrazioni minime inibenti 369
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 357
Analisi preliminare sull’impatto clinico-organizzativo della gestione delle ABSSSI: focus sui criteri di dimissione precoce 337
Non-granulomatous cerebellar infection by Acanthamoeba spp. in an immunocompetent host 332
Colonizzazione e trapianto di polmone: il possibile ruolo dei colonizzanti multiresistenti sugli eventi infettivi in uno studio pilota osservazionale-retrospettivo 330
Mapping the human genetic architecture of COVID-19 328
Peripheral biomarkers' panel for severe COVID-19 patients 325
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 320
Programma di vaccinazione antiMpox e screening infettivologico: opportunità di prevenzione in differenti categorie a rischio 315
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 315
Long Covid: analisi di casistica in follow-up a seguito di successive ondate epidemiche 314
Analisi retrospettiva su infezioni invasive e non invasive da batteri Gram negativi non fermentanti in pazienti ospedalizzati 313
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 310
Nuovi approci diagnostici nelle infezioni pneumococciche: possibile ruolo della Real-time PCR e dei biomarcatori 309
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 308
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 304
Antipneumococcal activity of ulifloxacin compared to levofloxacin and ciprofloxacin 299
Paediatric obstructive sleep apnoea syndrome (OSAS) is associated with tonsil colonisation by Streptococcus pyogenes 298
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 297
Case Report: Persistent strongyloidiasis complicated by recurrent meningitis in an HTLV seropositive Peruvian migrant resettled in Italy 292
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 289
Strategie di vaccinazione anti-pneumococcica nel paziente adulto HIV-positivo: confronto fra vaccino coniugato 13-valente e vaccino polisaccaridico 23-valente 287
Evaluation and Optimization of an ELISA Procedure to Quantify Antibodies Against Pneumococcal Polysaccharides Included in the 13-Valent Conjugate Vaccine 287
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 287
Un rarissimo caso di infestazione parassitaria cerebellare da Acanthamoeba spp. In soggetto immunocompetente: primo caso in Italia 284
Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region 284
Evolution of macrolide resistance in streptococcus pyogenes over 14 years in an area of central Italy 284
First report of spondylodiscitis due to vancomycin heteroresistant Staphylococcus capitis in immunocompetent host 282
Decline of Prevalence of Resistance Associated Substitutions to NS3 and NS5A inhibitors at DAA-failure in Hepatitis C Virus in Italy over the years 2015 to 2018 270
Pediatric spinal epidural abscess in an immunocompetent host without risk factors: Case report and review of the literature 268
Phacoemulsificator and sterile drapes contamination during cataract surgery: a microbiological study 267
Valutazione microbiologica del rischio infettivo nella chirurgia della cataratta 266
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 265
ERADICAZIONE DI INFEZIONE DA HCV DOPO TRATTAMENTO DI 8 SETTIMANE CON GRAZOPREVIR/ELBASVIR: CASE REPORT 263
Approccio perinatale al neonato che ha presentato malessere fetale 262
Prognostic bioindicators in severe COVID-19 patients 259
Serial KL-6 measurements in COVID-19 patients 256
Clinical and microbiological features of acute bacterialconjunctivitis at the primary eye care unit in a hospital of centralItaly 252
Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance. 252
HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART 251
Antimicrobial Susceptibility of Streptococcus pyogenes and Streptococcus pneumoniae: Surveillance from 1993 to 2004 in Central Italy 250
Decline of Prevalence of Resistance Associated Substitutions to NS3 and NS5A inhibitors at DAA-failure in Hepatitis C Virus in Italy over the years 2015 to 2018 250
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 250
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: a cohort study 247
Un caso di “insolita” spondilodiscite da Staphylococcus capitis 246
Large oligoclonal outbreak due to Klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC β-lactamase in a neonatal intensive care unit 244
Clindamycin-resistant Streptococcus pneumoniae 243
Predicting 2-drug antiretroviral regimen efficacy by genotypic susceptibility score: results from a cohort study 241
Descrizione di un'epidemia da Enterobacteriaceae multiresistenti in un'unità di terapia intensiva neonatale 241
Clinical and microbiological features of acute bacterial conjunctivitis at the primary eye care unit in a hospital of central Italy 241
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 241
Risposta immunitaria a lungo termine dopo vaccinazione antipneumococcica con vaccino coniugato 13-valente o vaccino polisaccaridico 23-valente in adulti HIV positivi 240
Current and emerging two-drug approaches for HIV-1 therapy in ART-naïve and ART-experienced, virologically suppressed patients 239
Resistenza ai beta-lattamici in Streptococcus pneumoniae: 10 anni di sorveglianza nell’area senese 236
Diagnosi di sarcoidosi in nuova diagnosi di HIV 236
Strategies for Maximising Lung Utilisation in Donors After Brain and Cardiac Death: A Narrative Review 234
Meningite postchirurgica e infezione di cute e tessuti molli da Acinetobacter baumannii extensively drug resistant (XDR) 234
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 233
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 232
Discovery of new Mycoplasma pneumoniae antigens by use of a whole genome lambda display library 231
Casistica di malattia reumatica e glomerulonefrite poststreptococcica: patologie passate o riemergenti? 227
Use of Miltefosine in a Patient With Mucosal Leishmaniasis and HIV-coinfection: A Challenge in Long-Term Management 227
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 226
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 225
Ridotta sensibilità a penicillina in Streptococcus pneumoniae: analisi microbiologica di ceppi di recente isolamento 225
Sierotipizzazione di isolati invasivi di Streptococcus pneumoniae: utilità della PCR multiplex nella sorveglianza epidemiologica 225
A complex outbreak of multiresistant Enterobacteriaceae producing the acquired AmpC-type beta-lactamase FOX-7 in a neonatal intensive care unit setting 225
Prevalence, Incidence and Predictors of Anal HPV Infection and HPV-Related Squamous Intraepithelial Lesions in a Cohort of People Living with HIV 225
PATOGENI COLONIZZANTI IL NASOFARINGE DI SOGGETTI HIV POSITIVI E HIV NEGATIVI 224
Impact of resistance mutations on virological efficacy of DTG-based maintenance two-drug regimens: an ARCA cohort study 224
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial) 223
Pneumococcal disease in a paediatric population in a hospital of central Italy: a clinical and microbiological case series from 1992 to 2006 223
Whole-genome sequencing reveals host factors underlying critical COVID-19 222
Distribution of different HBV DNA forms in plasma and peripheral blood mononuclear cells (PBMCs) of chronically infected patients with low or undetectable HBV plasma viremia 221
Valutazione della risposta al test IGRA in pazienti pediatrici contatto di TBC o con sospetto clinico di infezione attiva 219
MIASI CAVITARIA A LOCALIZZAZIONE NASALE DA OESTRUS OVIS: UN CASO CLINICO 219
Prevalence of M75 Streptococcus Pyogenes strains harboring slaa gene in patients affected by pediatric obstructive sleep apnea syndrome in Central Italy 219
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 218
WES profiling of COVID-19 217
Un raro caso di osteomielite da Moraxella osloensis e Staphylococcus capitis in giovane paziente immunocompetente 216
Sierotipizzazione, clonalità e chemiosensibilità di isolati invasivi di Streptococcus pneumoniae nell'area senese: basi per una corretta strategia vaccinale” 215
Totale 31.575
Categoria #
all - tutte 153.047
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.047


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.049 0 0 142 176 152 89 113 124 130 206 308 609
2022/20234.308 250 458 509 519 364 711 228 375 351 171 208 164
2023/20244.411 141 114 404 291 213 977 1.262 171 71 205 235 327
2024/20259.396 392 415 948 436 1.039 703 774 673 901 443 856 1.816
2025/202622.332 1.383 2.745 3.376 2.742 3.910 780 2.356 710 816 1.218 841 1.455
2026/20272.483 1.052 770 661 0 0 0 0 0 0 0 0 0
Totale 53.226